|
58
|
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
PAR-25-337 · National Institutes of Health · applied research
|
biomedical clinical
public health
materials manufacturing
|
$499,000 |
2024-12-31 |
2028-01-07 |
549 |
|
58
|
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
PAR-25-338 · National Institutes of Health · applied research
|
biomedical clinical
materials manufacturing
ai data science
|
$499,000 |
2024-12-31 |
2028-01-07 |
549 |
|
58
|
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
PAR-25-321 · National Institutes of Health · applied research
|
biomedical clinical
public health
materials manufacturing
|
— |
2024-12-10 |
2028-01-07 |
549 |
|
48
|
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
PAR-24-325 · National Institutes of Health · applied research
|
biomedical clinical
materials manufacturing
ai data science
|
— |
2024-11-06 |
2027-09-07 |
427 |
|
48
|
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
PAR-25-346 · National Institutes of Health · applied research
|
biomedical clinical
materials manufacturing
computing communications
|
— |
2024-12-11 |
2028-01-07 |
549 |
|
40
|
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
PAR-25-336 · National Institutes of Health · applied research
|
biomedical clinical
materials manufacturing
ai data science
|
— |
2024-12-16 |
2027-11-15 |
496 |
|
12
|
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
RFA-NS-25-021 · National Institutes of Health · applied research
|
biomedical clinical
public health
materials manufacturing
|
— |
2024-11-05 |
2026-09-28 |
83 |